197 related articles for article (PubMed ID: 20937311)
1. Mycobacterial cell-wall skeleton as a universal vaccine vehicle for antigen conjugation.
Paik TH; Lee JS; Kim KH; Yang CS; Jo EK; Song CH
Vaccine; 2010 Nov; 28(50):7873-80. PubMed ID: 20937311
[TBL] [Abstract][Full Text] [Related]
2. Adjuvant activity of mycobacterial fractions. I. Purification and in vivo adjuvant activity of cell wall skeletons of Mycobacterium bovis BCG, Nocardia asteroides 131 and Corynebacterium diphtheriae PW8.
Azuma I; Kanetsuna F; Taniyama T; Yamamura Y; Hori M
Biken J; 1975 Mar; 18(1):1-13. PubMed ID: 807194
[TBL] [Abstract][Full Text] [Related]
3. Improved immunogenicity of recombinant Mycobacterium bovis bacillus Calmette-Guérin strains expressing fusion protein Ag85A-ESAT-6 of Mycobacterium tuberculosis.
Deng YH; Sun Z; Yang XL; Bao L
Scand J Immunol; 2010 Oct; 72(4):332-8. PubMed ID: 20883318
[TBL] [Abstract][Full Text] [Related]
4. Gene-inducing program of human dendritic cells in response to BCG cell-wall skeleton (CWS), which reflects adjuvancy required for tumor immunotherapy.
Ishii K; Kurita-Taniguchi M; Aoki M; Kimura T; Kashiwazaki Y; Matsumoto M; Seya T
Immunol Lett; 2005 May; 98(2):280-90. PubMed ID: 15860229
[TBL] [Abstract][Full Text] [Related]
5. Vaccinations with T-helper type 1 directing adjuvants have different suppressive effects on the development of allergen-induced T-helper type 2 responses.
Trujillo-Vargas CM; Mayer KD; Bickert T; Palmetshofer A; Grunewald S; Ramirez-Pineda JR; Polte T; Hansen G; Wohlleben G; Erb KJ
Clin Exp Allergy; 2005 Aug; 35(8):1003-13. PubMed ID: 16120081
[TBL] [Abstract][Full Text] [Related]
6. Pseudo-rationale design of efficient TB vaccines: lesson from the mycobacterial 27-kDa lipoprotein.
Hovav AH; Bercovier H
Tuberculosis (Edinb); 2006; 86(3-4):225-35. PubMed ID: 16515885
[TBL] [Abstract][Full Text] [Related]
7. Modulation of immune responses in mice to recombinant antigens from PE and PPE families of proteins of Mycobacterium tuberculosis by the Ribi adjuvant.
Chaitra MG; Nayak R; Shaila MS
Vaccine; 2007 Oct; 25(41):7168-76. PubMed ID: 17709160
[TBL] [Abstract][Full Text] [Related]
8. Cell wall skeleton of Mycobacterium bovis BCG enhances the vaccine potential of antigen 85B against tuberculosis by inducing Th1 and Th17 responses.
Back YW; Choi S; Choi HG; Shin KW; Son YJ; Paik TH; Kim HJ
PLoS One; 2019; 14(3):e0213536. PubMed ID: 30849108
[TBL] [Abstract][Full Text] [Related]
9. Influence of immunisation with Mycobacterium bovis bacillus Calmette-Guérin on the sensitisation to inhaled allergens after infection with respiratory syncytial virus.
Vonberg RP; Mueller M; Emmendoerffer A; Freihorst J
Clin Exp Med; 2005 Dec; 5(4):177-83. PubMed ID: 16362797
[TBL] [Abstract][Full Text] [Related]
10. Frequency of IFN-gamma producing cells correlates with adjuvant enhancement of bacille Calmette-Guèrin induced protection against Mycobacterium bovis.
Logan KE; Chambers MA; Hewinson RG; Hogarth PJ
Vaccine; 2005 Dec; 23(48-49):5526-32. PubMed ID: 16105710
[TBL] [Abstract][Full Text] [Related]
11. The liposome-incorporating cell wall skeleton of Mycobacterium bovis bacillus Calmette-Guéin can directly enhance the susceptibility of cancer cells to lymphokine-activated killer cells through up-regulation of natural-killer group 2, member D ligands.
Miyazaki J; Kawai K; Kojima T; Oikawa T; Joraku A; Shimazui T; Nakaya A; Yano I; Nakamura T; Harashima H; Akaza H
BJU Int; 2011 Nov; 108(9):1520-6. PubMed ID: 21314815
[TBL] [Abstract][Full Text] [Related]
12. CpG-DNA stimulates cellular and humoral immunity and promotes Th1 differentiation in aged BALB/c mice.
Maletto B; Rópolo A; Morón V; Pistoresi-Palencia MC
J Leukoc Biol; 2002 Sep; 72(3):447-54. PubMed ID: 12223511
[TBL] [Abstract][Full Text] [Related]
13. Humoral and cell-mediated immune responses to live recombinant BCG-HIV vaccines.
Aldovini A; Young RA
Nature; 1991 Jun; 351(6326):479-82. PubMed ID: 2046750
[TBL] [Abstract][Full Text] [Related]
14. Immunization with heat-killed Mycobacterium bovis bacille Calmette-Guerin (BCG) in Eurocine L3 adjuvant protects against tuberculosis.
Haile M; Schröder U; Hamasur B; Pawlowski A; Jaxmar T; Källenius G; Svenson SB
Vaccine; 2004 Mar; 22(11-12):1498-508. PubMed ID: 15063575
[TBL] [Abstract][Full Text] [Related]
15. Immunomodulatory activity of novel adjuvant formulations based on Montanide ISA oil-based adjuvants and peptidoglycan monomer.
Habjanec L; Halassy B; Tomasić J
Int Immunopharmacol; 2008 May; 8(5):717-24. PubMed ID: 18387514
[TBL] [Abstract][Full Text] [Related]
16. Enhancement of immunologic tumor regression by intratumoral administration of dendritic cells in combination with cryoablative tumor pretreatment and Bacillus Calmette-Guerin cell wall skeleton stimulation.
Udagawa M; Kudo-Saito C; Hasegawa G; Yano K; Yamamoto A; Yaguchi M; Toda M; Azuma I; Iwai T; Kawakami Y
Clin Cancer Res; 2006 Dec; 12(24):7465-75. PubMed ID: 17189420
[TBL] [Abstract][Full Text] [Related]
17. Evidence for enhanced central memory priming by live Mycobacterium bovis BCG vaccine in comparison with killed BCG formulations.
Whelan AO; Wright DC; Chambers MA; Singh M; Hewinson RG; Vordermeier HM
Vaccine; 2008 Jan; 26(2):166-73. PubMed ID: 18055073
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of bovine cutaneous delayed-type hypersensitivity (DTH) to various test antigens and a mitogen using several adjuvants.
Hernández A; Yager JA; Wilkie BN; Leslie KE; Mallard BA
Vet Immunol Immunopathol; 2005 Mar; 104(1-2):45-58. PubMed ID: 15661330
[TBL] [Abstract][Full Text] [Related]
19. Induction of a regulatory T cell type 1 response reduces the development of atherosclerosis in apolipoprotein E-knockout mice.
Mallat Z; Gojova A; Brun V; Esposito B; Fournier N; Cottrez F; Tedgui A; Groux H
Circulation; 2003 Sep; 108(10):1232-7. PubMed ID: 12912803
[TBL] [Abstract][Full Text] [Related]
20. Optimization of cell-wall skeleton derived from Mycobacterium bovis BCG Tokyo 172 (SMP-105) emulsion in delayed-type hypersensitivity and antitumor models.
Miyauchi M; Murata M; Fukushima A; Sato T; Nakagawa M; Fujii T; Koseki N; Chiba N; Kashiwazaki Y
Drug Discov Ther; 2012 Aug; 6(4):218-25. PubMed ID: 23006993
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
